Nanexa AB announced that it has received SEK 17.2 million in funding from Novo Nordisk A/S

Nanexa AB (publ) announced a private placement of 10,000,000 shares at a price of SEK 1.72 per share for gross proceeds of SEK 17,200,000 on December 21, 2022. The transaction included participation from existing investor Novo Nordisk A/S.